SYNTARA LIMITED (SNT)
AI Coverage Rating: Active
ASX AI Signals has generated 4 signal for SNT during the last 90 days, indicating active trading activity and ongoing AI monitoring
Latest SNT Signals | |
| 26/06/2026 | SELL |
| 15/06/2026 | SELL |
| 14/06/2026 | SELL |
SNT Share Price | |
| Current Price | $0.023 |
| 52 Week High | $0.063 |
| 52 Week Low: | $0.019 |
| Trading at (% of 52 Week High) | 36.51% |
Business Overview
Syntara Limited (ASX: SNT) is an Australian company that specializes in developing and commercializing smart digital products, including advanced security and communication technology. The company focuses on innovation in areas such as cybersecurity, secure identity management, and digital transformation solutions.
ASX Sector Overview
Sector: Pharmaceuticals, Biotechnology & Life Sciences
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
Latest AI Recommendation
The SELL recommendation for SYNTARA LIMITED (SNT) is supported by the low current price indicating potential undervaluation risks and weak market sentiment. However, moderate confidence is maintained due to limited publicly available financial data and potential volatility in micro-cap stocks.
Latest SYNTARA LIMITED(SNT) News
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial